01—Abstract
Summary
Summary of the 8-K filed February 15, 2024. Cited figures are marked; the original filing is the authoritative source.
On February 15, 2024, The Cigna Group (NYSE: CI) disclosed that it entered into accelerated share repurchase (ASR) agreements with Deutsche Bank AG and Bank of America, N.A. to buy back $3.2 billiona of its common stock under its existing share repurchase program.
Cigna prepaid $3.2 billionb and received an initial delivery of approximately 7.6 million shares on February 15, 2024. The final number of shares repurchased will depend on the daily volume-weighted average share price over the term of the agreements, less a discount, so the total share count retired is not yet fixed. Final settlement is expected in the second quarter of 2024, and at that point Cigna may receive additional shares, make a cash payment, or deliver shares to the counterparties at its discretion.
The repurchase is part of a broader capital return plan. Management said the company is on track to repurchase $5 billionc of common stock over the first half of 2024, including this ASR, and expects the majority of discretionary cash flow to be directed to buybacks in 2024. The company had $10.6 billion of remaining authorization under its share repurchase program as of February 13, 2024.
Management characterized the transaction as a value-enhancing use of capital that reflects the growth and strength of its businesses. The 8-K is a disclosure of a capital allocation event rather than a financial results report, so it contains no earnings, revenue, or margin data. Investors should weigh the buyback as a signal of management confidence and a driver of per-share value, while recognizing that the final share count and settlement terms remain subject to market prices and contract adjustments.
02—Key points
Key Highlights
- Cigna entered into $3.2 billion of accelerated share repurchase agreements with Deutsche Bank AG and Bank of America, N.A. on February 14, 2024.
- On February 15, 2024, Cigna prepaid $3.2 billion and received an initial delivery of approximately 7.6 million shares.
- The final number of shares to be repurchased depends on the daily VWAP over the ASR term, less a discount, so total shares retired are not yet fixed.
- Final settlement is expected in the second quarter of 2024; Cigna may receive additional shares, pay cash, or deliver shares at its discretion.
- Management is on track to repurchase $5 billion of common stock in the first half of 2024, including this ASR.
- Management expects the majority of discretionary cash flow to go toward share repurchases in 2024.
- The existing repurchase program had $10.6 billion of remaining authority as of February 13, 2024.
03—Questions
Frequently Asked Questions
How many shares has Cigna received so far under the ASR?
Cigna received an initial delivery of approximately 7.6 million shares on February 15, 2024, in exchange for the $3.2 billion prepayment. The final share count will be set at settlement.
When will the ASR be finalized?
Final settlement is expected to occur in the second quarter of 2024. At that time, the number of shares repurchased will be determined based on the VWAP over the term, and adjustments may result in additional shares to Cigna or a cash or share payment by Cigna.
How much buyback capacity does Cigna have left?
As of February 13, 2024, the company had $10.6 billion of remaining authorization under its existing share repurchase program. The ASR is funded under this program.
What is the total buyback target for 2024?
Management said it is on track to repurchase $5 billion of common stock over the first half of 2024, inclusive of this $3.2 billion ASR, and expects most discretionary cash flow to go to share repurchases this year.
Does this filing include financial results?
No. This 8-K covers only the ASR transaction and an accompanying press release. It does not contain earnings, revenue, or margin information, so investors should refer to the company's periodic reports for financial performance.
04—Continue